Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histocompatibility antigens in progressive systemic sclerosis (scleroderma).

N S Birnbaum, G P Rodnan, B S Rabin

    The Journal of Rheumatology
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Natural History of Progressive Systemic Sclerosis (difuse Scleroderma).

    Indian journal of dermatology and venereology·2017
    Same author

    Influences on life-span of NZB/W mice.

    Immunology today·2014
    Same author

    Effect of Cyclosporin-A on Hepatic and Renal Allograft Mononuclear Cell Infiltration.

    Transplantation proceedings·2010
    Same author

    Characterization of the central nervous system innervation of the rat spleen using viral transneuronal tracing.

    The Journal of comparative neurology·2001
    Same author

    Identification of delta- and mu-type opioid receptors on human and murine dendritic cells.

    Journal of neuroimmunology·2001
    Same author

    Associations between stress, trait negative affect, acute immune reactivity, and antibody response to hepatitis B injection in healthy young adults.

    Health psychology : official journal of the Division of Health Psychology, American Psychological Association·2001
    Same journal

    Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

    The Journal of rheumatology·2026
    Same journal

    Concurrent Calcium Pyrophosphate Deposition Disease and Gout of the Cervical Spine Presenting With Subacute Neck Pain and Radiculopathy.

    The Journal of rheumatology·2026
    Same journal

    The Need for Weight Communication Guidelines in Pediatric Rheumatology.

    The Journal of rheumatology·2026
    Same journal

    Bimekizumab Improves Health Status and Work Productivity, With Reduced Productivity Costs, to 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis.

    The Journal of rheumatology·2026
    Same journal

    Qualitative Analysis of Physical Activity Engagement in Women with Self-Reported SLE: The Role of Symptoms, Healthcare Providers, and the Environment.

    The Journal of rheumatology·2026
    Same journal

    Tumoral Calcinosis-like Calcification of the Proximal Interphalangeal Joint Mimicking Rheumatoid Arthritis Flare.

    The Journal of rheumatology·2026
    See all related articles

    This study investigated major histocompatibility (HLA) antigens in scleroderma patients. No significant differences in HLA antigen distribution were found in patients with progressive systemic sclerosis (PSS) compared to controls.

    Area of Science:

    • Immunogenetics
    • Rheumatology
    • Dermatology

    Background:

    • Progressive systemic sclerosis (PSS), also known as scleroderma, is a complex autoimmune disease.
    • The role of human leukocyte antigen (HLA) genes in autoimmune disease susceptibility is well-established.
    • Understanding HLA antigen distribution in PSS may offer insights into disease pathogenesis.

    Purpose of the Study:

    • To determine the distribution of major histocompatibility (HLA) antigens in patients with progressive systemic sclerosis (PSS).
    • To compare HLA antigen frequencies between PSS patients (diffuse scleroderma and CREST syndrome variants) and healthy controls.

    Main Methods:

    • A total of 106 PSS patients and 208 healthy controls were analyzed.
    • The microcytotoxicity technique was used to test for the presence of 18 different HLA antigens.

    Related Experiment Videos

  • Patients were stratified into classical diffuse scleroderma and CREST syndrome groups.

    • Main Results:

    • No significant alterations in the frequency of any tested HLA antigen were observed in the overall PSS group.
    • Analysis of the diffuse scleroderma and CREST syndrome subpopulations also revealed no significant HLA antigen frequency changes.
    • Statistical correction for multiple antigen testing did not alter these findings.

    Conclusions:

    • The study found no significant association between the investigated HLA antigens and progressive systemic sclerosis.
    • HLA antigen distribution does not appear to be a major genetic factor in the pathogenesis of PSS or its variants.
    • Further research may be needed to explore other genetic or environmental factors in scleroderma development.